Mesenchymal neoplasms of the urinary bladder: a comprehensive review with focus on cross-sectional imaging findings.
Imaging mesenchymal neoplasms
Imaging urinary bladder neoplasms
Mesenchymal neoplasms
Mesenchymal neoplasms of urinary bladder
Urinary bladder neoplasms
Journal
Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
28
03
2022
accepted:
19
05
2022
revised:
16
05
2022
pubmed:
16
6
2022
medline:
23
7
2022
entrez:
15
6
2022
Statut:
ppublish
Résumé
Mesenchymal neoplasms of the urinary bladder are exceedingly rare and display remarkable diversity. These tumors demonstrate distinct pathological features as well as variable biological behavior and cross-sectional imaging findings. The rarity of tumors, nonspecific symptoms and seemingly normal cystoscopic findings (particularly with small and exophytic tumors) frequently lead to misdiagnosis or missed diagnosis. While some tumors display characteristic cross-sectional imaging findings that may suggest a diagnosis, imaging findings are mostly nonspecific. Histopathological examination is required for accurate diagnosis, management and prognostication. The purpose of this article is to review the cross-sectional imaging findings of a diverse spectrum of mesenchymal tumors of the urinary bladder.
Identifiants
pubmed: 35704069
doi: 10.1007/s00261-022-03568-4
pii: 10.1007/s00261-022-03568-4
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2881-2895Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Verma S, Rajesh A, Prasad SR, Gaitonde K, Lall CG, Mouraviev V, et al. Urinary Bladder Cancer: Role of MR Imaging. RadioGraphics. 2012;32(2):371-87.
pubmed: 22411938
doi: 10.1148/rg.322115125
Wong-You-Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA. From the Archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation. Radiographics. 2006;26(2):553-80.
pubmed: 16549617
doi: 10.1148/rg.262055172
Chung AD, Schieda N, Flood TA, Cagiannos I, Kielar AZ, McInnes MD, et al. Suburothelial and extrinsic lesions of the urinary bladder: radiologic and pathologic features with emphasis on MR imaging. Abdom Imaging. 2015;40(7):2573-88.
pubmed: 26048699
doi: 10.1007/s00261-015-0467-z
Hatfield BS, Mochel MC, Smith SC. Mesenchymal Neoplasms of the Genitourinary System: A Selected Review with Recent Advances in Clinical, Diagnostic, and Molecular Findings. Surg Pathol Clin. 2018;11(4):837-76.
pubmed: 30447845
doi: 10.1016/j.path.2018.07.008
Tavora F, Kryvenko ON, Epstein JI. Mesenchymal tumours of the bladder and prostate: an update. Pathology. 2013;45(2):104-15.
pubmed: 23250042
doi: 10.1097/PAT.0b013e32835c768b
Chmielecki J, Crago AM, Rosenberg M, O'Connor R, Walker SR, Ambrogio L, et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet. 2013;45(2):131-2.
pubmed: 23313954
pmcid: 3984043
doi: 10.1038/ng.2522
Huang SC, Huang HY. Solitary fibrous tumor: An evolving and unifying entity with unsettled issues. Histol Histopathol. 2019;34(4):313-34.
pubmed: 30431144
Mahajan P, Casanova M, Ferrari A, Fordham A, Trahair T, Venkatramani R. Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges. Curr Probl Cancer. 2021;45(4):100768.
pubmed: 34244015
doi: 10.1016/j.currproblcancer.2021.100768
Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31(4):509-20.
pubmed: 17414097
doi: 10.1097/01.pas.0000213393.57322.c7
Ahmadi H, Duddalwar V, Daneshmand S. Diagnosis and Staging of Bladder Cancer. Hematol Oncol Clin North Am. 2021;35(3):531-41.
pubmed: 33958149
doi: 10.1016/j.hoc.2021.02.004
Mirmomen SM, Shinagare AB, Williams KE, Silverman SG, Malayeri AA. Preoperative imaging for locoregional staging of bladder cancer. Abdom Radiol (NY). 2019;44(12):3843-57.
pubmed: 31377833
doi: 10.1007/s00261-019-02168-z
Katabathina VS, Rajebi H, Chen M, Restrepo CS, Salman U, Vikram R, et al. Genetics and imaging of pheochromocytomas and paragangliomas: current update. Abdom Radiol (NY). 2020;45(4):928-44.
pubmed: 31069476
doi: 10.1007/s00261-019-02044-w
Surabhi VR, Chua S, Patel RP, Takahashi N, Lalwani N, Prasad SR. Inflammatory Myofibroblastic Tumors: Current Update. Radiol Clin North Am. 2016;54(3):553-63.
pubmed: 27153788
doi: 10.1016/j.rcl.2015.12.005
Carrasquillo JA, Chen CC, Jha A, Ling A, Lin FI, Pryma DA, et al. Imaging of Pheochromocytoma and Paraganglioma. J Nucl Med. 2021;62(8):1033-42.
pubmed: 34330739
pmcid: 8833868
doi: 10.2967/jnumed.120.259689
Helpap B. Nonepithelial neoplasms of the urinary bladder. Virchows Archiv. 2001;439(4):497-503.
pubmed: 11710636
doi: 10.1007/s004280100479
Lu H, Male M, Jiang K, Ye Z, Song D, Xia D. Clinical significance of functional and anatomical classifications in paraganglioma of the urinary bladder. Urol Oncol. 2019;37(6):354 e9- e17.
Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19(8):859–72.
Harik LR, Merino C, Coindre JM, Amin MB, Pedeutour F, Weiss SW. Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases. Am J Surg Pathol. 2006;30(7):787-94.
pubmed: 16819319
doi: 10.1097/01.pas.0000208903.46354.6f
Hoekman K, van Doorn J, Gloudemans T, Maassen JA, Schuller AG, Pinedo HM. Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma. Clin Endocrinol (Oxf). 1999;51(2):247-53.
pubmed: 10468998
doi: 10.1046/j.1365-2265.1999.00833.x
Lee TK, Miyamoto H, Osunkoya AO, Guo CC, Weiss SW, Epstein JI. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases. Am J Surg Pathol. 2010;34(4):502-9.
pubmed: 20154594
doi: 10.1097/PAS.0b013e3181cf326d
Mouli S, Casalino DD, Nikolaidis P. Imaging features of common and uncommon bladder neoplasms. Radiol Clin North Am. 2012;50(2):301–16, vi.
Tanguay C, Harvey I, Houde M, Srigley JR, Tetu B. Leiomyosarcoma of urinary bladder following cyclophosphamide therapy: report of two cases. Mod Pathol. 2003;16(5):512-4.
pubmed: 12748258
doi: 10.1097/01.MP.0000068237.38715.D9
Zukerman Z, Schiavina R, Borghesi M, Brunocilla E, Vagnoni V, Pirini MG, et al. Smooth muscle tumor of uncertain malignant potential of the urinary bladder: a case report and review of the literature. Clin Genitourin Cancer. 2013;11(4):e6-9.
pubmed: 23810438
doi: 10.1016/j.clgc.2013.04.023
Keraliya AR, Tirumani SH, Shinagare AB, Zaheer A, Ramaiya NH. Solitary Fibrous Tumors: 2016 Imaging Update. Radiol Clin North Am. 2016;54(3):565-79.
pubmed: 27153789
doi: 10.1016/j.rcl.2015.12.006
Shanbhogue AK, Prasad SR, Takahashi N, Vikram R, Zaheer A, Sandrasegaran K. Somatic and visceral solitary fibrous tumors in the abdomen and pelvis: cross-sectional imaging spectrum. Radiographics. 2011;31(2):393-408.
pubmed: 21415186
doi: 10.1148/rg.312105080
Acosta AM, Demicco EG, Dal Cin P, Hirsch MS, Fletcher CDM, Jo VY. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions. Mod Pathol. 2021;34(2):469-77.
pubmed: 32908253
doi: 10.1038/s41379-020-00670-0
Shelmerdine SC, Lorenzo AJ, Gupta AA, Chavhan GB. Pearls and Pitfalls in Diagnosing Pediatric Urinary Bladder Masses. Radiographics. 2017;37(6):1872-91.
pubmed: 29019749
doi: 10.1148/rg.2017170031
Tavora F, Montgomery E, Epstein JI. A series of vascular tumors and tumorlike lesions of the bladder. Am J Surg Pathol. 2008;32(8):1213-9.
pubmed: 18580491
doi: 10.1097/PAS.0b013e31816293c5
Cheng L, Nascimento AG, Neumann RM, Nehra A, Cheville JC, Ramnani DM, et al. Hemangioma of the urinary bladder. Cancer. 1999;86(3):498-504.
pubmed: 10430259
doi: 10.1002/(SICI)1097-0142(19990801)86:3<498::AID-CNCR19>3.0.CO;2-6
Lee C, Kim B, Song B, Park JH, Moon KC. Clinicopathologic Features of Benign Neurogenic Tumor of Urinary Bladder. Int J Surg Pathol. 2018;26(3):221-8.
pubmed: 29172920
doi: 10.1177/1066896917742722
Cheng L, Scheithauer BW, Leibovich BC, Ramnani DM, Cheville JC, Bostwick DG. Neurofibroma of the urinary bladder. Cancer. 1999;86(3):505-13.
pubmed: 10430260
doi: 10.1002/(SICI)1097-0142(19990801)86:3<505::AID-CNCR20>3.0.CO;2-A
Kriegshauser JS, Conley CR, Hentz JG. Bladder wall fat on computed tomography with pathologic correlation. Clin Imaging. 2013;37(3):509-13.
pubmed: 23142003
doi: 10.1016/j.clinimag.2012.10.001
Folpe AL, Kwiatkowski DJ. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol. 2010;41(1):1-15.
pubmed: 19604538
doi: 10.1016/j.humpath.2009.05.011
Prasad SR, Sahani DV, Mino-Kenudson M, Narra VR, Humphrey PA, Menias CO, et al. Neoplasms of the perivascular epithelioid cell involving the abdomen and the pelvis: cross-sectional imaging findings. J Comput Assist Tomogr. 2007;31(5):688-96.
pubmed: 17895778
doi: 10.1097/rct.0b013e318031912f
Wu YL, Lang L, Ma Q, Wu F, Zhang Y, Chen W, et al. Perivascular Epithelioid Cell Tumor of Urinary Bladder. Am J Clin Pathol. 2021;156(1):56-71.
pubmed: 33336255
doi: 10.1093/ajcp/aqaa204
Neumann NM, Haffner MC, Argani P, Kao CS, Epstein JI. Histopathologic Characterization of Bladder Perivascular Epithelioid Cell Neoplasms (PEComa): A Series of 11 Cases With a Subset Having TFE3 Rearrangements. Am J Surg Pathol. 2021;45(2):169-77.
pubmed: 33002920
doi: 10.1097/PAS.0000000000001592
Williamson SR, Bunde PJ, Montironi R, Lopez-Beltran A, Zhang S, Wang M, et al. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features. Am J Surg Pathol. 2013;37(10):1619-26.
pubmed: 23797724
doi: 10.1097/PAS.0b013e318293729d
Xuesong D, Hong G, Weiguo Z. Bladder Perivascular Epithelioid Cell Tumor: Dynamic CT and MRI Presentation of 2 Cases With 2-year Follow-up and Review of the Literature. Clin Genitourin Cancer. 2019;17(5):e916-e22.
pubmed: 31327725
doi: 10.1016/j.clgc.2019.06.016
Tirumani SH, Shinagare AB, Hargreaves J, Jagannathan JP, Hornick JL, Wagner AJ, et al. Imaging features of primary and metastatic malignant perivascular epithelioid cell tumors. AJR Am J Roentgenol. 2014;202(2):252-8.
pubmed: 24450662
doi: 10.2214/AJR.13.10909
Crona J, Taieb D, Pacak K. New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification. Endocr Rev. 2017;38(6):489-515.
pubmed: 28938417
pmcid: 5716829
doi: 10.1210/er.2017-00062
Sajjan RS, Gavra M, Agrawal K, Syed R, Bomanji J. 68Ga-DOTATATE PET/MR Imaging of Urinary Bladder Paraganglioma. Clin Nucl Med. 2015;40(8):692-4.
pubmed: 26018712
doi: 10.1097/RLU.0000000000000797
Roman-Gonzalez A, Jimenez C. Malignant pheochromocytoma-paraganglioma: pathogenesis, TNM staging, and current clinical trials. Curr Opin Endocrinol Diabetes Obes. 2017;24(3):174-83.
pubmed: 28234804
doi: 10.1097/MED.0000000000000330
Nguyen A, Fassas S, Freidberg N, Sullo E, Whalen M. Recurrence and treatment of adult primary nonmetastatic bladder rhabdomyosarcoma: A systematic review. Urol Oncol. 2021;39(11):774-80.
pubmed: 34332845
doi: 10.1016/j.urolonc.2021.07.008
Nigro KG, MacLennan GT. Rhabdomyosarcoma of the bladder and prostate. J Urol. 2005;173(4):1365.
pubmed: 15758805
doi: 10.1097/01.ju.0000156904.32546.33